Page last updated: 2024-08-21

liriodenine and Ovarian Neoplasms

liriodenine has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ali, HM; Hashim, NM; Hassan, Z; Majid, NA; Nordin, N; Rahman, MA	1

Other Studies

1 other study(ies) available for liriodenine and Ovarian Neoplasms

Article	Year
Liriodenine, an aporphine alkaloid from Enicosanthellum pulchrum, inhibits proliferation of human ovarian cancer cells through induction of apoptosis via the mitochondrial signaling pathway and blocking cell cycle progression. Drug design, development and therapy, 2015, Volume: 9 Topics: Annonaceae; Antineoplastic Agents, Phytogenic; Apoptosis; Aporphines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mitochondria; Ovarian Neoplasms; Signal Transduction; Structure-Activity Relationship	2015

Article

Year

Liriodenine, an aporphine alkaloid from Enicosanthellum pulchrum, inhibits proliferation of human ovarian cancer cells through induction of apoptosis via the mitochondrial signaling pathway and blocking cell cycle progression.

Drug design, development and therapy, 2015, Volume: 9

Topics: Annonaceae; Antineoplastic Agents, Phytogenic; Apoptosis; Aporphines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mitochondria; Ovarian Neoplasms; Signal Transduction; Structure-Activity Relationship

2015